World News Insights
1-3 Minute Gist

All Topics Article

Indian Drug Maker Vies for Betapharm

Wall Street Journal

Keywords:

LyrArc Article Gist
Both Ranbaxy and Dr.Reddy's, two of India's largest pharmaceutical companies, are bidding for Betapharm, Germany's fourth largest generic drugs maker. Ranbaxy's bid at 500 million euros was 50 million euros higher than Dr. Reddy's. Betapharm based in Augsburg, Germany, has sales of 161 million euros, and a workforce of 350. For Dr. Reddy's this is a way to get a foothold in a branded generic market in a developed country, says Dr. Reddy. This will be the largest foreign acquisition for an Indian pharmaceutical company.

Pharmaceutical companies with Generics products are changing the marketplace.

07/26/2005

With growing demand for low cost affordable drugs the growth in sales of generics.

Grouped Articles

Indian Drug Maker Vies for Betapharm

Wall Street Journal 02/09/2006

Branded Drugs Settling More Generic Suits

Wall Street Journal 01/17/2006

Generics Eat Into Pfizer's Profit; Costs Offset Novartis Sales Gain

Wall Street Journal 01/20/2006

As Generics Pummel Its Drugs, Pfizer Faces Uncertain Future

Wall Street Journal 01/05/2006

Teva to Acquire Ivax, Another Maker of Generic Drugs

New York Times 07/26/2005

Heard on the Street

Wall Street Journal 07/26/2005

Indian pharmaceutical companies and the growing demand in India.

02/09/2006

The rapidly growing Indian pharmaceutical companies. The Indian market $8 billion today will grow to $30 billion in the next 10 years as more people get access to better healthcare. Sales in the Middle East, Africa and Latin America, and outsourcing manufacture for western companies are additional sources of growth for these companies.

Grouped Articles

Looking East, Big Pharma Cuts Prices

BusinessWeek 04/15/2010

India Administers Price-Cap Dose to Drug Companies

Wall Street Journal 09/22/2014

Indian Drug Maker Vies for Betapharm

Wall Street Journal 02/09/2006

Transcending the genre

Economist 11/08/2007

India's Drug Firms May Boost a Healthy Portfolio

Wall Street Journal 12/17/2007

Indian Companies Hit Their Stride

BusinessWeek 09/17/2007

Indian pharmaceutical companies and export markets.

02/09/2006

Grouped Articles

Indian Drugmakers Target Niche Markets

Wall Street Journal 04/19/2016

In Trade Deal, a Shift on Generics

Wall Street Journal 05/17/2007

Transcending the genre

Economist 11/08/2007

India's Drug Firms May Boost a Healthy Portfolio

Wall Street Journal 12/17/2007

Indian Companies Hit Their Stride

BusinessWeek 09/17/2007

Outsourcing the Drug Industry

BusinessWeek 09/04/2008


Support LyrArc

We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.

Support Lyrarc from as small as $1


Copyright © 2006 - 2026 Intelilinks LLC
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us